Skip to main content
Equibles

Diane Parks

Board Member

Kura Oncology, Inc. (KURA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Diane Parks

Diane Parks is recorded as Board Member at Kura Oncology, Inc. (KURA). Earlier roles on record: Board Member at Celularity Inc (CELU) until September 29, 2026. Celularity Inc reported in an 8-K filed September 29, 2026 that Diane Parks resigned as the Board. Kura Oncology, Inc. reported in an 8-K filed June 4, 2026 that Diane Parks was appointed Class III director, effective June 4, 2026. Kura Oncology, Inc. reported in an 8-K filed June 2, 2023 that Diane Parks was appointed Class III director, effective May 31, 2023.

“In relation to this appointment, Diane Parks notified the Company of her decision to resign from the Board, effective as of the Effective Time.”
Celularity Inc Form 8-K, filed September 29, 2026 · Read the filing
“elected Diane Parks, Mary T. Szela and Michael J. Vasconcelles, M.D. as Class III directors to hold office until our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal”
Kura Oncology, Inc. Form 8-K, filed June 4, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kura Oncology, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.